Clear.bio
PrivateLast Round
VC Round
Sep 29, 2025
Company Overview
Clear.bio operates in Healthcare & Life Sciences and is based in Amsterdam. Its latest recorded funding round was a VC Round in September 2025.
Clear.bio is a healthtech company that provides a digital therapeutics platform with personalized nutrition plans to help users manage and reverse type 2 diabetes.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Medical Devices, Healthcare Analytics, Personalization, Health IoT
Business Model
B2C
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clear.bio Comparables
Compare Clear.bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Una Health | 81% | |
| DexCom | 81% | |
| Signos | 75% |
For institutional investors. Book with your work email.
Clear.bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 29, 2025 | ||||
| VC Round | Nov 9, 2022 | ||||
| VC Round | Mar 10, 2022 | ||||
| VC Round | Nov 3, 2021 | ||||
| Accelerator | Nov 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Clear.bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizon Flevoland | VC Round |
| Mustard Seed Maze | VC Round |
| Future Food Fund | VC Round |
| Antler | VC Round, Accelerator |
| Invest International | VC Round |
| Future Food Fund | VC Round |
| Achmea | VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 29, 2025
$1.84M round raised.
- Mar 30, 2025
Added Cliquemedia, a digital media SMB, as a customer.
For institutional investors. Book with your work email.
Clear.bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Clear.bio's valuation, stock price, and market status.
Is Clear.bio a public or private company?
Clear.bio is a private company.
What is the current stock price of Clear.bio?
Clear.bio is a private company, so its shares have no public market price. Caplight tracks Clear.bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Clear.bio worth (valuation)?
Valuation information for Clear.bio is not publicly available.
Can I buy Clear.bio stock?
Clear.bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Clear.bio's last funding round?
Clear.bio's most recent funding round was VC Round on September 29, 2025.
Who are the main investors in Clear.bio?
Key investors in Clear.bio include Mustard Seed Maze, Antler, Achmea, Healthy.Capital.
Will Clear.bio IPO soon?
No public IPO plans have been announced for Clear.bio.
How can I track Clear.bio secondary market activity?
Caplight tracks bids, offers, and trades in Clear.bio's shares on secondary markets.